NUCLIDIUM
Swiss clinical-stage biotechnology company pioneering the development of next-generation copper-based radiopharmaceuticals for the diagnosis and treatment of cancer
NUCLIDIUM has raised €113M across 2 funding rounds from 13 investors, most recently a Series B round in May 2026. Based in Zurich, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Zurich, Switzerlandwww.nuclidium.com ↗
Total raised
€113M
€112,536,933
Funding rounds
2
Investors
13
distinct backers
Active since
2025-07
latest 2026-05
Funding by year
EUR raised per year · 2026 YTDNUCLIDIUM — funding by year — interactive chart.
Data table
| NUCLIDIUM — funding by year | |
|---|---|
| 2025 | €84M |
| 2026 | €29M |
Signals
High confidenceRaise-next likelihood27
base rate 48% for Series B
- ▼ Raised very recently
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood20
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▼ Young (<3y)
- ▲ Recent equity round, but funding momentum is down (may be rescue financing)
Timing: too soon vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-05-29 | Series B | €29M | Angelini Ventures,Aurea,Bayern Kapital,Existing investors,Kurma Growth Opportunities Fund,Neva SGR+3 more | View deal → |
| 2025-07-11 | Series B | €84M | Angelini Ventures,Bayern Kapital,DeepTech & Climate Fonds (DTCF),Eurazeo,Existing investors,HighLight Capital+5 more | View deal → |
Investors
13Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData